1. Home
  2. GEN vs UTHR Comparison

GEN vs UTHR Comparison

Compare GEN & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEN
  • UTHR
  • Stock Information
  • Founded
  • GEN 1982
  • UTHR 1996
  • Country
  • GEN United States
  • UTHR United States
  • Employees
  • GEN N/A
  • UTHR N/A
  • Industry
  • GEN Computer Software: Prepackaged Software
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEN Technology
  • UTHR Health Care
  • Exchange
  • GEN Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • GEN 18.8B
  • UTHR 16.1B
  • IPO Year
  • GEN N/A
  • UTHR 1999
  • Fundamental
  • Price
  • GEN $27.86
  • UTHR $364.10
  • Analyst Decision
  • GEN Buy
  • UTHR Buy
  • Analyst Count
  • GEN 4
  • UTHR 14
  • Target Price
  • GEN $28.75
  • UTHR $370.86
  • AVG Volume (30 Days)
  • GEN 3.7M
  • UTHR 297.9K
  • Earning Date
  • GEN 01-30-2025
  • UTHR 02-19-2025
  • Dividend Yield
  • GEN 1.79%
  • UTHR N/A
  • EPS Growth
  • GEN N/A
  • UTHR 25.10
  • EPS
  • GEN 0.99
  • UTHR 22.72
  • Revenue
  • GEN $3,863,000,000.00
  • UTHR $2,756,200,000.00
  • Revenue This Year
  • GEN $3.91
  • UTHR $26.32
  • Revenue Next Year
  • GEN $3.38
  • UTHR $10.61
  • P/E Ratio
  • GEN $28.19
  • UTHR $16.02
  • Revenue Growth
  • GEN 2.44
  • UTHR 25.04
  • 52 Week Low
  • GEN $19.08
  • UTHR $208.62
  • 52 Week High
  • GEN $31.72
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • GEN 35.15
  • UTHR 47.56
  • Support Level
  • GEN $27.27
  • UTHR $356.00
  • Resistance Level
  • GEN $28.14
  • UTHR $364.95
  • Average True Range (ATR)
  • GEN 0.71
  • UTHR 9.20
  • MACD
  • GEN -0.33
  • UTHR -0.45
  • Stochastic Oscillator
  • GEN 14.36
  • UTHR 41.67

About GEN Gen Digital Inc.

Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Share on Social Networks: